{"organizations": [], "uuid": "12618f8a9e2a866176e81b1ae46d191c8a034a19", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-endocyte-and-itm-announce-supply-a/brief-endocyte-and-itm-announce-supply-agreement-idUSASB0C7EO", "country": "US", "domain_rank": 408, "title": "BRIEF-Endocyte And ITM Announce Supply Agreement", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-26T15:16:00.000+02:00", "replies_count": 0, "uuid": "12618f8a9e2a866176e81b1ae46d191c8a034a19"}, "author": "", "url": "https://www.reuters.com/article/brief-endocyte-and-itm-announce-supply-a/brief-endocyte-and-itm-announce-supply-agreement-idUSASB0C7EO", "ord_in_thread": 0, "title": "BRIEF-Endocyte And ITM Announce Supply Agreement", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "itm announce supply agreement reuters", "sentiment": "negative"}, {"name": "itm", "sentiment": "negative"}, {"name": "endocyte inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 17 PM / Updated 6 minutes ago BRIEF-Endocyte And ITM Announce Supply Agreement Reuters Staff Feb 26 (Reuters) - Endocyte Inc: * ENDOCYTE AND ITM ANNOUNCE SUPPLY AGREEMENT FOR NO-CARRIER-ADDED LUTETIUM FOR THE PHASE 3 VISION TRIAL * ENDOCYTE INC - UNDER SUPPLY AGREEMENT, ITM TO SUPPLY TO CO, MEDICAL RADIOISOTOPE NO-CARRIER-ADDED LUTETIUM, ENDOLUCINBETA * ENDOCYTE INC - PHASE 3 VISION TRIAL EXPECTED TO BE INITIATED BY ENDOCYTE IN Q2 OF 2018 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-26T15:16:00.000+02:00", "crawled": "2018-02-26T15:27:09.026+02:00", "highlightTitle": ""}